Irene Suárez-Pereira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Irene Suárez-Pereira has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Ángel Manuel Carrión
Departamento de Fisiología, Anatomía y Biología Celular, Universidad Pablo de Olavide, Sevilla, Spain
7 shared publications - Esther Berrocoso
Neuropsychopharmacology & Psychobiology Research Group, Department of Neuroscience, University of Cádiz, Cádiz, Spain
5 shared publications - Meritxell Llorca-Torralba
Neuropsychopharmacology & Psychobiology Research Group, Department of Neuroscience, University of Cádiz, Cádiz, Spain
4 shared publications - Ángela Fontán-Lozano
División de Neurociencias, Universidad Pablo de Olavide de Sevilla, Sevilla, Spain
4 shared publications - Lidia Bravo
Neuropsychopharmacology & Psychobiology Research Group, Department of Neuroscience, University of Cádiz, Cádiz, Spain
3 shared publications - Alicia Sánchez-García
Instituto de la Grasa (CSIC), Campus Universitario Pablo de Olavide (UPO), Sevilla, Spain
2 shared publications
Latest Publications
- Open Access
- 6 May 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 678, 125692
Venlafaxine-PLGA nanoparticles provide a fast onset of action in an animal model of depression via nose-to-brain
- 6 May 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 678, 125692
Open AccessVenlafaxine-PLGA nanoparticles provide a fast onset of action in an animal model of depression via nose-to-brain
- Open Access
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S605
SEX DIFFERENCES IN LOCUS COERULEUS AND BEHAVIOUR IN C57BL/6J MICE
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S605
Open AccessSEX DIFFERENCES IN LOCUS COERULEUS AND BEHAVIOUR IN C57BL/6J MICE
- Open Access
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S551
LOCUS COERULEUS-NORADRENERGIC PROJECTIONS CONTRIBUTE TO HIPPOCAMPAL-DEPENDENT MEMORY DEFICITS IN A MOUSE MODEL OF CHRONIC NEUROPATHIC PAIN.
- 5 November 2023
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 15, S551
Open AccessLOCUS COERULEUS-NORADRENERGIC PROJECTIONS CONTRIBUTE TO HIPPOCAMPAL-DEPENDENT MEMORY DEFICITS IN A MOUSE MODEL OF CHRONIC NEUROPATHIC PAIN.
- 20 August 2021
- Published by Wolters Kluwer Health in Pain
- Vol. 163 (5) , 943-954
Nerve injury induces transient locus coeruleus activation over time: role of the locus coeruleus–dorsal reticular nucleus pathway
The transition from acute to chronic pain results in maladaptive brain remodeling, as characterized by sensorial hypersensitivity and the ensuing appearance of emotional disorders. Using the chronic constriction injury of the sciatic nerve as a model of neuropathic pain in male Sprague–Dawley rats, we identified time-dependent plasticity of locus coeruleus (LC) neurons related to the site of injury, ipsilateral (LCipsi) or contralateral (LCcontra) to the lesion, hypothesizing that the LC→dorsal reticular nucleus (DRt) pathway is involved in the pathological nociception associated with chronic pain. LCipsi inactivation with lidocaine increased cold allodynia 2 days after nerve injury but not later. However, similar blockade of LCcontra reduced cold allodynia 7 and 30 days after inducing neuropathy but not earlier. Furthermore, lidocaine blockade of the LCipsi or LCcontra reversed pain-induced depression 30 days after neuropathy. Long-term pain enhances phosphorylated cAMP-response element binding protein expression in the DRtcontra but not in the DRtipsi. Moreover, inactivation of the LCcontra→DRtcontra pathway using dual viral-mediated gene transfer of designer receptor exclusively activated by designer drugs produced consistent analgesia in evoked and spontaneous pain 30 days postinjury. This analgesia was similar to that produced by spinal activation of α2-adrenoreceptors. Furthermore, chemogenetic inactivation of the LCcontra→DRtcontra pathway induced depressive-like behaviour in naïve animals, but it did not modify long-term pain-induced depression. Overall, nerve damage activates the LCipsi, which temporally dampens the neuropathic phenotype. However, the ensuing activation of a LCcontra→DRtcontra facilitatory pain projection contributes to chronic pain, whereas global bilateral LC activation contributes to associated depressive-like phenotype.
- 20 August 2021
- Published by Wolters Kluwer Health in Pain
- Vol. 163 (5) , 943-954
Nerve injury induces transient locus coeruleus activation over time: role of the locus coeruleus–dorsal reticular nucleus pathway
The transition from acute to chronic pain results in maladaptive brain remodeling, as characterized by sensorial hypersensitivity and the ensuing appearance of emotional disorders. Using the chronic constriction injury of the sciatic nerve as a model of neuropathic pain in male Sprague–Dawley rats, we identified time-dependent plasticity of locus coeruleus (LC) neurons related to the site of injury, ipsilateral (LCipsi) or contralateral (LCcontra) to the lesion, hypothesizing that the LC→dorsal reticular nucleus (DRt) pathway is involved in the pathological nociception associated with chronic pain. LCipsi inactivation with lidocaine increased cold allodynia 2 days after nerve injury but not later. However, similar blockade of LCcontra reduced cold allodynia 7 and 30 days after inducing neuropathy but not earlier. Furthermore, lidocaine blockade of the LCipsi or LCcontra reversed pain-induced depression 30 days after neuropathy. Long-term pain enhances phosphorylated cAMP-response element binding protein expression in the DRtcontra but not in the DRtipsi. Moreover, inactivation of the LCcontra→DRtcontra pathway using dual viral-mediated gene transfer of designer receptor exclusively activated by designer drugs produced consistent analgesia in evoked and spontaneous pain 30 days postinjury. This analgesia was similar to that produced by spinal activation of α2-adrenoreceptors. Furthermore, chemogenetic inactivation of the LCcontra→DRtcontra pathway induced depressive-like behaviour in naïve animals, but it did not modify long-term pain-induced depression. Overall, nerve damage activates the LCipsi, which temporally dampens the neuropathic phenotype. However, the ensuing activation of a LCcontra→DRtcontra facilitatory pain projection contributes to chronic pain, whereas global bilateral LC activation contributes to associated depressive-like phenotype.
- Open Access
- 4 January 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-12
Steroid hormones sulfatase inactivation extends lifespan and ameliorates age-related diseases
Aging and fertility are two interconnected processes. From invertebrates to mammals, absence of the germline increases longevity. Here we show that loss of function of sul-2, the Caenorhabditis elegans steroid sulfatase (STS), raises the pool of sulfated steroid hormones, increases longevity and ameliorates protein aggregation diseases. This increased longevity requires factors involved in germline-mediated longevity (daf-16, daf-12, kri-1, tcer-1 and daf-36 genes) although sul-2 mutations do not affect fertility. Interestingly, sul-2 is only expressed in sensory neurons, suggesting a regulation of sulfated hormones state by environmental cues. Treatment with the specific STS inhibitor STX64, as well as with testosterone-derived sulfated hormones reproduces the longevity phenotype of sul-2 mutants. Remarkably, those treatments ameliorate protein aggregation diseases in C. elegans, and STX64 also Alzheimer’s disease in a mammalian model. These results open the possibility of reallocating steroid sulfatase inhibitors or derivates for the treatment of aging and aging related diseases.
- 4 January 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-12
Open AccessSteroid hormones sulfatase inactivation extends lifespan and ameliorates age-related diseases
Aging and fertility are two interconnected processes. From invertebrates to mammals, absence of the germline increases longevity. Here we show that loss of function of sul-2, the Caenorhabditis elegans steroid sulfatase (STS), raises the pool of sulfated steroid hormones, increases longevity and ameliorates protein aggregation diseases. This increased longevity requires factors involved in germline-mediated longevity (daf-16, daf-12, kri-1, tcer-1 and daf-36 genes) although sul-2 mutations do not affect fertility. Interestingly, sul-2 is only expressed in sensory neurons, suggesting a regulation of sulfated hormones state by environmental cues. Treatment with the specific STS inhibitor STX64, as well as with testosterone-derived sulfated hormones reproduces the longevity phenotype of sul-2 mutants. Remarkably, those treatments ameliorate protein aggregation diseases in C. elegans, and STX64 also Alzheimer’s disease in a mammalian model. These results open the possibility of reallocating steroid sulfatase inhibitors or derivates for the treatment of aging and aging related diseases.
- 1 August 2020
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 115, 96-115
Pain in neuropsychiatry: Insights from animal models
- 1 August 2020
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 115, 96-115
Pain in neuropsychiatry: Insights from animal models
- 4 July 2020
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 104, 110030
Selective deletion of Caspase-3 gene in the dopaminergic system exhibits autistic-like behaviour
- 4 July 2020
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 104, 110030
Selective deletion of Caspase-3 gene in the dopaminergic system exhibits autistic-like behaviour
- Open Access
- 1 December 2019
- Published by Elsevier in Data in Brief
- Vol. 27, 104415
Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis
- 1 December 2019
- Published by Elsevier in Data in Brief
- Vol. 27, 104415
Open AccessData regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis
- Open Access
- 1 June 2019
- Published by Elsevier in Biological Psychiatry
- Vol. 85 (12) , 1021-1035
Chemogenetic Silencing of the Locus Coeruleus–Basolateral Amygdala Pathway Abolishes Pain-Induced Anxiety and Enhanced Aversive Learning in Rats
- 1 June 2019
- Published by Elsevier in Biological Psychiatry
- Vol. 85 (12) , 1021-1035
Open AccessChemogenetic Silencing of the Locus Coeruleus–Basolateral Amygdala Pathway Abolishes Pain-Induced Anxiety and Enhanced Aversive Learning in Rats